These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28875682)

  • 1. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
    Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and
    Zhou T; Tang X; Zhang W; Feng J; Wu W
    Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
    Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
    Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
    Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
    Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
    Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
    Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
    Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
    Wang A; Li S
    BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
    Zhao YX; Liu DX; Liang WQ; Ye ZW
    J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
    Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
    Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
    Zheng J; Ji Y; Shao C; Jing L; Wang Y
    J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
    Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
    Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
    Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.
    Zhao Y; Liu J; Sun X; Zhang ZR; Gong T
    Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment with Rhizoma Paridis and Rhizoma Curcuma longa extracts and 10-hydroxycamptothecin enhances the antitumor effect in H22 tumor model by increasing the plasma concentration.
    Liu Z; Li H; Fan Y; Liu Y; Man S; Yu P; Gao W
    Biomed Pharmacother; 2016 Oct; 83():627-634. PubMed ID: 27459119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
    Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
    Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.